Clover Health Investments (CLOV) 2024 Wells Fargo Healthcare Conference summary

2024 financial performance and guidance

• Achieved first quarter of GAAP net income profitability in Q2 2024 and $42 million EBITDA profit in H1 2024.

• Increased full-year 2024 guidance for revenue, cost ratios (including MCR), and EBITDA, now guiding adjusted EBITDA between $50 million and $65 million.

• Insurance revenue and gross profit have grown at double-digit rates, with industry-leading medical cost ratios and a strong, debt-free balance sheet.

• SG&A costs reduced through restructuring and outsourcing, enabling scalable growth without significant incremental cost.

• Capital priorities include continued investment in core plans and technology, Counterpart Health expansion, and authorized stock buybacks.

Technology and differentiation

• Proprietary, AI-powered, cloud-based platform (Clover Assistant) integrates with most EHRs, providing real-time, actionable insights at the point of care.

• Enables earlier detection and management of chronic diseases, improving outcomes and reducing costs; A/B testing shows chronic disease diagnosis 12–18 months earlier.

• Home care offering is physician-led, using the same technology for longitudinal patient management.

• Technology is updated quarterly via agile development, with a feedback loop to refine recommendations.

• Focused on PPO chassis, offering high physician choice and not delegating risk, resulting in pure performance metrics.

Market strategy and growth

• Majority of members are in New Jersey, with presence in Georgia, South Carolina, Texas, and Pennsylvania; about two-thirds of members receive at least one technology-powered visit annually.

• Market share in New Jersey is around 10%, with significant organic growth potential; best-in-class technology and care stack cited as competitive advantages.

• 2024 revenue growth guidance was raised after strong Q2 results and a Star Rating increase for payment year 2025.

• No significant impact from regulatory changes like the Two-Midnight Rule in 2024.

• Expansion beyond New Jersey is ongoing, with opportunities to increase technology adoption in other states.